The global intragastric balloons market size reached US$ 63.6 Million in 2023. Looking forward, the publisher expects the market to reach US$ 157.8 Million by 2032, exhibiting a growth rate (CAGR) of 10.6% during 2023-2032.
An intragastric balloon is a saline- or gas-filled inflatable silicone balloon that is temporarily placed inside the stomach for losing weight. It is inserted through a non-surgical endoscopic procedure to confine the amount of food stored by the stomach, thereby providing an early feeling of satiety. It also aids in preserving the anatomy of the stomach and is bio-compatible while having negligible or no side-effects. As a result, the device is commonly used by individuals suffering from obesity and having a body mass index (BMI) ranging from 30 to 70.
The increasing prevalence of obesity is one of the key factors driving the growth of the market. Owing to sedentary lifestyles and unhealthy eating habits, a significant portion of the world's population is suffering from weight-related health concerns. This has consequently augmented the demand for various medically certified weight-loss procedures, including intragastric balloons. Furthermore, growing consumer preference for minimally invasive (MI) surgeries is also providing a boost to the market growth. Intragastric balloons serve as an effective non-surgical alternative for weight-loss as they are inserted orally and do not require any incisions on the body. Additionally, various technological advancements and product innovations are also creating a positive outlook for the market growth. Manufacturers are focusing on creating product variants with minimal side-effects, such as ulceration, gastric erosion and nausea, and are also designing balloons with adjustable gas/saline volumes. Other factors, including increasing health consciousness among consumers, and extensive research and development (R&D) activities, are projected to drive the market further.
Double Intragastric Balloon
Triple Intragastric Balloon
Gas Filling
Non-Surgical
Diabetes
Diet Control
Weight-Loss
Pre-Operative Weight Reduction
Others
Ambulatory Surgical Centers
Others
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
What are the key regional markets?
What has been the impact of COVID-19 on the global intragastric balloons market?
What is the breakup of the market based on the product?
What is the breakup of the market based on the filling material?
What is the breakup of the market based on the implanting procedure?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global intragastric balloons market and who are the key players?
What is the degree of competition in the industry?
An intragastric balloon is a saline- or gas-filled inflatable silicone balloon that is temporarily placed inside the stomach for losing weight. It is inserted through a non-surgical endoscopic procedure to confine the amount of food stored by the stomach, thereby providing an early feeling of satiety. It also aids in preserving the anatomy of the stomach and is bio-compatible while having negligible or no side-effects. As a result, the device is commonly used by individuals suffering from obesity and having a body mass index (BMI) ranging from 30 to 70.
The increasing prevalence of obesity is one of the key factors driving the growth of the market. Owing to sedentary lifestyles and unhealthy eating habits, a significant portion of the world's population is suffering from weight-related health concerns. This has consequently augmented the demand for various medically certified weight-loss procedures, including intragastric balloons. Furthermore, growing consumer preference for minimally invasive (MI) surgeries is also providing a boost to the market growth. Intragastric balloons serve as an effective non-surgical alternative for weight-loss as they are inserted orally and do not require any incisions on the body. Additionally, various technological advancements and product innovations are also creating a positive outlook for the market growth. Manufacturers are focusing on creating product variants with minimal side-effects, such as ulceration, gastric erosion and nausea, and are also designing balloons with adjustable gas/saline volumes. Other factors, including increasing health consciousness among consumers, and extensive research and development (R&D) activities, are projected to drive the market further.
Key Market Segmentation:
The report provides an analysis of the key trends in each sub-segment of the global intragastric balloons market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, filling material, implanting procedure, application and end-user.Breakup by Product:
Single Intragastric BalloonDouble Intragastric Balloon
Triple Intragastric Balloon
Breakup by Filling Material:
Saline FillingGas Filling
Breakup by Implanting Procedure:
SurgicalNon-Surgical
Breakup by Application:
ObesityDiabetes
Diet Control
Weight-Loss
Pre-Operative Weight Reduction
Others
Breakup by End-User:
Hospitals and ClinicsAmbulatory Surgical Centers
Others
Breakup by Region:
North AmericaUnited States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Apollo Endosurgery, Obalon Therapeutics Inc., ReShape Medical Inc., Medicone, Medsil, Allurion Technologies Inc., Helioscopie, Spatz Fgia Inc., PlenSat, Districlass Medical SA, Endalis, Lexel SRL, Silimed Inc., Shandong Institute of Medical Instruments, etc.Key Questions Answered in This Report:
How has the global intragastric balloons market performed so far and how will it perform in the coming years?What are the key regional markets?
What has been the impact of COVID-19 on the global intragastric balloons market?
What is the breakup of the market based on the product?
What is the breakup of the market based on the filling material?
What is the breakup of the market based on the implanting procedure?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global intragastric balloons market and who are the key players?
What is the degree of competition in the industry?
Table of Contents
1 Preface3 Executive Summary13 Value Chain Analysis15 Price Indicators
2 Scope and Methodology
4 Introduction
5 Global Intragastric Balloons Market
6 Market Breakup by Product
7 Market Breakup by Filling Material
8 Market Breakup by Implanting Procedure
9 Market Breakup by Application
10 Market Breakup by End-User
11 Market Breakup by Region
12 SWOT Analysis
14 Porters Five Forces Analysis
16 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Apollo Endosurgery
- Obalon Therapeutics Inc.
- ReShape Medical Inc.
- Medicone
- Medsil
- Allurion Technologies Inc.
- Helioscopie
- Spatz Fgia Inc.
- PlenSat
- Districlass Medical SA
- Endalis
- Lexel SRL
- Silimed Inc.
- Shandong Institute of Medical Instruments
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 142 |
| Published | July 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 63.6 Million |
| Forecasted Market Value ( USD | $ 157.8 Million |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
